ATF4 and prostate carcinoma: This tissue-specific CHOP expression might differentiate the role of PERK pathway in prostate cancer and colorectal cancer, because CHOP is largely known as a pro-apoptotic protein, while ATF4 is primarily pro-cancer development and progression.